G. Della Porta

发表

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient.

M. Barbacid, M. Pierotti, E. Reddy, 1984, Science.

DNA methylation affecting the transforming activity of the human Ha-ras oncogene.

M. Borrello, M. Pierotti, R. Donghi, 1987, Cancer research.

Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach

N. Maffulli, E. Giordano, C. Selleri, 2022, Artificial cells, nanomedicine, and biotechnology.

A t(2;3)(q12-13;p24-25) in follicular thyroid adenomas.

G. Sozzi, M. Pierotti, S. Pilotti, 1992, Cancer genetics and cytogenetics.

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

M. Pierotti, C. Lanzi, I. Bongarzone, 1992, Oncogene.

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

I D Hay, N. Berger, M. Santoro, 1992, The Journal of clinical investigation.

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

M. Borrello, M. Santoro, A. Fusco, 1994, Cancer research.

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

M. Pierotti, S. Pilotti, R. Donghi, 1993, The Journal of clinical investigation.

Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.

U. Pastorino, G. Sozzi, M. Pierotti, 1992, Cancer research.

The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31.

P. Radice, G. Sozzi, M. Pierotti, 1991, Oncogene.

Structure and expression of oncogenes in surgical specimens of human breast carcinomas.

G. Cattoretti, M. Pierotti, S. Pilotti, 1988, British Journal of Cancer.

Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients.

U. Pastorino, M. Pierotti, S. Pilotti, 1991, Cancer research.

Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.

M. Borrello, M. Santoro, A. Fusco, 1992, Oncogene.

CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset.

F. Rilke, G. Cattoretti, D. Delia, 1988, Blood.

Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.

M. Borrello, M. Pierotti, D. Delia, 1992, Cytometry.

Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.

M. Borrello, M. Pierotti, D. Delia, 1989, Cancer research.

HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.

M. Borrello, P. Radice, M. Pierotti, 1987, Oncogene.

Loss of heterozygosity in human germinal tumors.

P. Radice, M. Pierotti, S. Pilotti, 1989, Cytogenetics and cell genetics.

Human TRK proto-oncogene maps to chromosome 1q32-q41.

P. Radice, G. Sozzi, M. Pierotti, 1990, Oncogene.

Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).

A. Santoro, M. Castellano, G. Sozzi, 1990, British Journal of Cancer.

Homozygous intragenic loss of the WT1 locus in a sporadic intralobar wilms' tumor

P. Radice, M. Pierotti, S. Pilotti, 1993, International journal of cancer.

Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma.

F. Rilke, G. Sozzi, M. Pierotti, 1988, Cancer genetics and cytogenetics.

bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

M. Pierotti, D. Delia, F. Pezzella, 1992, Blood.

Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.

M. Pierotti, S. Pilotti, G. Manenti, 1994, European journal of cancer.

Chromosomal abnormalities in a primary small cell lung cancer.

M. Borrello, G. Sozzi, M. Pierotti, 1987, Cancer genetics and cytogenetics.

Chromosome abnormalities and fragile sites in human melanoma.

G. Sozzi, M. Pierotti, M. Miozzo, 1990, Cancer genetics and cytogenetics.

DNA methylation of coding and non-coding regions of the human H-RAS gene in normal and tumor tissues.

M. Borrello, M. Pierotti, S. Pilotti, 1992, Oncogene.

Detection of two TaqI polymorphisms in the VTR region of the human HRAS1 oncogene.

M. Borrello, P. Radice, M. Pierotti, 1986, Cytogenetics and cell genetics.

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

C. Carcano, M. Borrello, M. Pierotti, 1993, Molecular and cellular biology.

Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.

R. Barale, G. Sozzi, D. Reali, 1985, Mutation research.

Human papillomavirus genomes in male urethral cells.

F. Rilke, M. Pierotti, S. Pilotti, 1992, The American journal of pathology.

Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies.

G. Cattoretti, D. Delia, D. Ballinari, 1988, Immunology.